Profil
Tim Tasker is currently the Chief Medical Officer & Vice President-Development at Nxera Pharma UK Ltd. He previously worked as the Executive Vice President-Clinical Development at Evotec SE, the Principal at GlaxoSmithKline LLC, and the Chief Medical Officer & Executive Vice President at Nxera Pharma Co., Ltd.
Aktive Positionen von Tim Tasker
| Unternehmen | Position | Beginn |
|---|---|---|
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Tim Tasker
| Unternehmen | Position | Ende |
|---|---|---|
| EVOTEC SE | Technik-/Wissenschafts-/F&E-Leiter | 30.04.2009 |
| NXERA PHARMA CO., LTD. | Technik-/Wissenschafts-/F&E-Leiter | - |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Evotec SE
Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Nxera Pharma Co., Ltd.
Nxera Pharma Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops bio pharmaceutical products | Health Technology |
Nxera Pharma UK Ltd.
Nxera Pharma UK Ltd. Pharmaceuticals: MajorHealth Technology Designs and develops new medicines targeting G protein-coupled receptors | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
















